Arbutus Biopharma Corp Increase (Decrease) in Deferred Revenue
Arbutus Biopharma Corp (ABUS) reported Increase (Decrease) in Deferred Revenue of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-12
CAD
| Period end | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|
| 2012-12-31 | -652.02K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 360.69K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 2.98M CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 703.34K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | -$9.62M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | -$9.62M derived: sum of 3 quarters · filed 2026-08-12 | -$10.43M 10-K · filed 2026-03-23 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$9.62M derived: sum of 2 quarters · filed 2026-08-12 | -$10.43M 10-Q · filed 2025-11-13 | -$10.91M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$9.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$10.43M 10-Q · filed 2026-08-12 | -$10.91M derived: sum of 3 quarters · filed 2026-08-12 | -$11.03M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$812.00K 10-Q · filed 2026-05-13 | -$1.29M derived: sum of 2 quarters · filed 2026-05-13 | -$1.41M derived: sum of 3 quarters · filed 2026-05-13 | -$1.93M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$600.00K derived: sum of 2 quarters · filed 2026-03-23 | -$1.11M derived: sum of 3 quarters · filed 2026-03-23 | -$1.36M 10-K · filed 2026-03-23 | ||
| 2024-09-30 | -$123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$636.00K derived: sum of 2 quarters · filed 2025-11-13 | -$880.00K 10-Q · filed 2025-11-13 | -$1.20M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$757.00K 10-Q · filed 2025-08-06 | -$1.07M derived: sum of 3 quarters · filed 2025-08-06 | -$4.29M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | -$244.00K 10-Q · filed 2025-05-14 | -$559.00K derived: sum of 2 quarters · filed 2025-05-14 | -$3.78M derived: sum of 3 quarters · filed 2025-05-14 | -$6.80M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$3.54M derived: sum of 2 quarters · filed 2025-03-27 | -$6.56M derived: sum of 3 quarters · filed 2025-03-27 | -$10.66M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | -$3.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$6.25M derived: sum of 2 quarters · filed 2024-11-06 | -$10.35M 10-Q · filed 2024-11-06 | -$13.36M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | -$3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$7.13M 10-Q · filed 2024-08-08 | -$10.14M derived: sum of 3 quarters · filed 2024-08-08 | -$12.49M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$4.10M 10-Q · filed 2024-05-02 | -$7.11M derived: sum of 2 quarters · filed 2024-05-02 | -$9.46M derived: sum of 3 quarters · filed 2024-05-02 | -$20.49M derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$5.36M derived: sum of 2 quarters · filed 2024-03-05 | -$16.39M derived: sum of 3 quarters · filed 2024-03-05 | $22.45M 10-K · filed 2024-03-05 | ||
| 2022-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$13.38M derived: sum of 2 quarters · filed 2023-11-07 | $25.46M 10-Q · filed 2023-11-07 | $25.46M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | -$11.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $27.82M 10-Q · filed 2023-08-03 | $27.82M derived: sum of 3 quarters · filed 2023-08-03 | $27.82M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $38.84M 10-Q · filed 2023-05-04 | $38.84M derived: sum of 2 quarters · filed 2023-05-04 | $38.84M derived: sum of 3 quarters · filed 2023-05-04 | $38.84M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | |||||
| 2018-03-31 | -$1.02M 10-Q · filed 2018-05-04 | $1.71M derived: sum of 2 quarters · filed 2018-05-04 | -$5.03M derived: sum of 3 quarters · filed 2018-05-04 | -$5.69M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2017-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$4.01M derived: sum of 2 quarters · filed 2018-03-16 | -$4.67M derived: sum of 3 quarters · filed 2018-03-16 | $2.73M 10-K · filed 2018-03-16 | ||
| 2017-09-30 | -$6.74M 10-Q · filed 2017-11-02 | -$7.39M derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2017-06-30 | -$653.00K 10-Q · filed 2017-08-03 | $6.74M 10-Q · filed 2017-08-03 | $6.74M derived: sum of 3 quarters · filed 2018-05-04 | $6.04M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2017-03-31 | $7.39M 10-Q · filed 2018-05-04 | $7.39M derived: sum of 2 quarters · filed 2018-05-04 | $6.70M derived: sum of 3 quarters · filed 2018-05-04 | $6.48M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$696.00K derived: sum of 2 quarters · filed 2018-03-16 | -$909.00K derived: sum of 3 quarters · filed 2018-03-16 | -$1.07M 10-K · filed 2018-03-16 | ||
| 2016-09-30 | -$696.00K 10-Q · filed 2017-11-02 | -$909.00K derived: sum of 2 quarters · filed 2017-11-02 | -$1.07M 10-Q · filed 2017-11-02 | -$16.21M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | -$213.00K 10-Q · filed 2017-08-03 | -$370.00K 10-Q · filed 2017-08-03 | -$15.51M derived: sum of 3 quarters · filed 2018-03-16 | -$12.50M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-03-31 | -$157.00K 10-Q · filed 2017-05-04 | -$15.30M derived: sum of 2 quarters · filed 2018-03-16 | -$12.29M derived: sum of 3 quarters · filed 2018-03-16 | -$11.96M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2015-12-31 | -$15.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$12.13M derived: sum of 2 quarters · filed 2018-03-16 | -$11.80M derived: sum of 3 quarters · filed 2018-03-16 | -$13.09M 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $3.01M 10-Q · filed 2016-11-03 | $3.35M derived: sum of 2 quarters · filed 2016-11-03 | $2.05M 10-Q · filed 2016-11-03 | $3.29M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-06-30 | $334.00K 10-Q · filed 2016-08-04 | -$957.00K 10-Q · filed 2016-08-04 | $276.00K derived: sum of 3 quarters · filed 2017-03-22 | -$530.00K derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-03-31 | -$1.29M 10-Q · filed 2016-05-04 | -$58.00K derived: sum of 2 quarters · filed 2017-03-22 | -$864.00K derived: sum of 3 quarters · filed 2017-03-22 | -$409.00K derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2014-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $427.00K derived: sum of 2 quarters · filed 2017-03-22 | $882.00K derived: sum of 3 quarters · filed 2017-03-22 | $13.17M 10-K · filed 2017-03-22 | ||
| 2014-09-30 | -$806.00K 10-Q · filed 2015-11-05 | -$351.00K derived: sum of 2 quarters · filed 2015-11-05 | $11.94M 10-Q · filed 2015-11-05 | $11.20M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-06-30 | $455.00K 10-Q · filed 2015-08-07 | $12.74M 10-Q · filed 2015-08-07 | $12.00M derived: sum of 3 quarters · filed 2016-03-09 | $12.46M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-03-31 | $12.29M 10-Q · filed 2015-05-06 | $11.55M derived: sum of 2 quarters · filed 2016-03-09 | $12.01M derived: sum of 3 quarters · filed 2016-03-09 | $12.47M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2013-12-31 | -$742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$280.00K derived: sum of 2 quarters · filed 2016-03-09 | $182.00K derived: sum of 3 quarters · filed 2016-03-09 | -$153.00K 10-K · filed 2016-03-09 | -$153.14K 6-K · filed 2014-03-06 | |
| 2013-09-30 | $462.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $924.00K derived: sum of 2 quarters · filed 2014-11-07 | $589.00K 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $462.00K 10-Q · filed 2014-11-07 | -$734.00K 10-Q · filed 2014-08-14 | $127.00K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $861.00K 10-Q · filed 2014-05-14 | |||||
| 2012-12-31 | -$655.00K 10-K · filed 2015-03-13 | -$655.34K 6-K · filed 2014-03-06 | ||||
| 2011-12-31 | $354.66K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |